These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 26621103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis.
    Olmes G, Büttner-Herold M, Ferrazzi F, Distel L, Amann K, Daniel C.
    Arthritis Res Ther; 2016 Apr 18; 18():90. PubMed ID: 27091114
    [Abstract] [Full Text] [Related]

  • 5. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis.
    Dai C, Liu Z, Zhou H, Li L.
    Chin Med J (Engl); 2001 Aug 18; 114(8):864-8. PubMed ID: 11780369
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological significance of tubulointerstitial CD68 macrophages in proliferative lupus nephritis.
    Chen J, Cui L, Ouyang J, Wang J, Xu W.
    Clin Rheumatol; 2022 Sep 18; 41(9):2729-2736. PubMed ID: 35616755
    [Abstract] [Full Text] [Related]

  • 7. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis.
    Endo N, Tsuboi N, Furuhashi K, Shi Y, Du Q, Abe T, Hori M, Imaizumi T, Kim H, Katsuno T, Ozaki T, Kosugi T, Matsuo S, Maruyama S.
    Nephrol Dial Transplant; 2016 Dec 18; 31(12):2023-2033. PubMed ID: 27242373
    [Abstract] [Full Text] [Related]

  • 8. [Phenotypic characteristics of infiltrated inflammatory cells, renal tubular epithelial cells and interstitial cells and their possible roles in the outcome of human drug-associated interstitial nephritis].
    Yang L, Li X, Zheng X.
    Zhonghua Yi Xue Za Zhi; 2001 Jan 25; 81(2):73-7. PubMed ID: 11798853
    [Abstract] [Full Text] [Related]

  • 9. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.
    Parodis I, Ding H, Zickert A, Arnaud L, Larsson A, Svenungsson E, Mohan C, Gunnarsson I.
    Scand J Rheumatol; 2017 Jul 25; 46(4):263-272. PubMed ID: 27973968
    [Abstract] [Full Text] [Related]

  • 10. Glomerular macrophage is an indicator of early treatment response in diffuse proliferative lupus nephritis.
    Cheunsuchon B, Incharoen P, Chawanasuntorapoj R, Chanchairujira T, Shayakul C.
    J Med Assoc Thai; 2013 Feb 25; 96 Suppl 2():S246-51. PubMed ID: 23590049
    [Abstract] [Full Text] [Related]

  • 11. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
    Chen S, Liu Z, Chen H, Zhou H, Wang J, Li L.
    Chin Med J (Engl); 2002 Sep 25; 115(9):1301-7. PubMed ID: 12411099
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH, Dutch Working Party on systemic lupus erythematosus.
    Ann Rheum Dis; 2012 Jun 25; 71(6):966-73. PubMed ID: 22128082
    [Abstract] [Full Text] [Related]

  • 13. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.
    Clin Nephrol; 1996 Sep 25; 46(3):170-5. PubMed ID: 8879851
    [Abstract] [Full Text] [Related]

  • 14. Periostin: a novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients.
    Wantanasiri P, Satirapoj B, Charoenpitakchai M, Aramwit P.
    Lupus; 2015 Jul 25; 24(8):835-45. PubMed ID: 25593049
    [Abstract] [Full Text] [Related]

  • 15. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul 25; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 16. Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
    Li C, Yap DYH, Chan G, Wen YB, Li H, Tang C, Li XM, Li XW, Chan TM.
    J Rheumatol; 2019 Nov 25; 46(11):1478-1484. PubMed ID: 30877215
    [Abstract] [Full Text] [Related]

  • 17. Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis.
    Park DJ, Kang JH, Lee JW, Lee KE, Kim TJ, Park YW, Lee JS, Choi YD, Lee SS.
    Lupus; 2017 Oct 25; 26(11):1139-1148. PubMed ID: 28420060
    [Abstract] [Full Text] [Related]

  • 18. Histologic versus clinical remission in proliferative lupus nephritis.
    Malvar A, Pirruccio P, Alberton V, Lococo B, Recalde C, Fazini B, Nagaraja H, Indrakanti D, Rovin BH.
    Nephrol Dial Transplant; 2017 Aug 01; 32(8):1338-1344. PubMed ID: 26250434
    [Abstract] [Full Text] [Related]

  • 19. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
    Vandepapelière J, Aydin S, Cosyns JP, Depresseux G, Jadoul M, Houssiau FA.
    Lupus; 2014 Feb 01; 23(2):159-65. PubMed ID: 24300780
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
    Ding H, Kharboutli M, Saxena R, Wu T.
    Clin Exp Immunol; 2016 Apr 01; 184(1):11-8. PubMed ID: 26616478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.